InTheMoney Stocks

Gilead Sciences Sets Up As A Beautiful Short

252 0 4
The biotech sector is in one of the biggest bubbles since the era. Some of the largest biotechnology companies in the world have doubled and tripled their size in the last year. One such stock is Gilead Sciences             , Inc. (NASDAQ:GILD). The stock is hovering up 100% from its lows a year ago and has a market cap of $128 billion.

Reasons For The Short:

1. Biotech sector in a bubble with cracks emerging.

2. Gildead Sciences is up 100% in the last year with no significant pull backs.

3. The valuation is unstustainable for Gilead Sciences             in the near term.

4. The stock has not been able to push through the technically important $85.00 level.

Overall, this sector has been an area where money has continued to flow. The music appears like it is coming to a stop. Gilead should have a pull back to $76.00 then $65.00.

Gareth Soloway

Get our detailed entry/exits and live calls as we enter swing trading positions in the Research Center.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out